April 22 (Reuters) - Abeona Therapeutics ( ABEO ) said
on Monday the U.S. health regulator had declined to approve its
treatment for a rare skin blistering condition.
(Reporting by Pratik Jain in Bengaluru; Editing by Sriraj
Kalluvila)